Fusion Guided Biopsy: The Future of Predicting Prostate Cancer

There has been a new development in the field of oncology to predict the occurrence of prostate cancer, as well as its aggressiveness. This involves a new method, known as fusion guided biopsy. It is a targeted MRI and ultrasound method of biopsy which stands to become the new hallmark of prostate cancer detection, says Howard Frey, a Director at the Center for Urologic Oncology at Valley-Mount Sinai Comprehensive Cancer Care.

• UroNav Technology now available: The Valley-Mount Sinai Comprehensive Cancer Care is now offering the UroNav Fusion Biopsy System to out-patients of the hospital as a standardized procedure. The new technology is advanced enough to detect and identify the presence of prostrate cancer, the second most common cancer seen amongst men. This cancer is much more complicated to detect due to its distinct lack of symptoms in early stages.
• More accurate biopsies:The UroNav Fusion Biopsy System involves fusing MRI images from before the biopsy of the prostate with an ultrasonic biopsy captured in real-time to identify potential danger sites which can then undergo a precise biopsy. This leads to a more precise ability to identify the lethal tumors from the non-life-threatening ones during the biopsy.
• Much better process compared to the standard one:Compared to the conventional method, where there is no particularly targeted area, this is much safer and efficient. In the past, if the prostrate is larger than usual, there was a possibility of not identifying a potentially dangerous tumor. In fusion biopsy however, an MRI scan is initially taken, and once an area of suspicion is found, the scan is combined with a real-timeultrasonic scan of the region which provides a specific region to biopsy. This can be used to

find more dangerous and aggressive tumors and cancers.

The results obtained from fusion biopsy are more accurate and efficient, and can be used to aid patients in choosing the most appropriate treatment plan.

About AuthorDr. Echt and his team at the Prostate Seed Institute offer the most highly sophisticated methods of radiation therapy available in the United States, equal to that found in major medical center and academic settings. These include prostate seed implantation, high dose radiation implants, and external beam radiation with image-guided and intensity-modulated (IGRT and IMRT) capabilities.

Dr. Echt and his team at the Prostate Seed Institute offer the most highly sophisticated methods of radiation therapy available in the United States, equal to that found in major medical center and academic settings. These include prostate seed impla